Rossari Biotech

  • Market Cap: Small Cap
  • Industry: Specialty Chemicals
  • ISIN: INE02A801020
  • NSEID: ROSSARI
  • BSEID: 543213
INR
509.50
-3.25 (-0.63%)
BSENSE

Aug 10

BSE+NSE Vol: 38.24 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Styrenix Perfor.
Bhansali Engg.
Tatva Chintan
Paushak
DDev Plastiks
NOCIL
Vishnu Chemicals
Rossari Biotech
Jubilant Agri
S H Kelkar & Co.
Camlin Fine
Why is Rossari Biotech Ltd ?
1
Company has a low Debt to Equity ratio (avg) at 0.07 times
2
Negative results in Mar 26
  • OPERATING PROFIT TO INTEREST(Q) Lowest at 8.53 times
  • DEBT-EQUITY RATIO(HY) Highest at 0.33 times
  • INTEREST(Q) Highest at Rs 9.06 cr
3
Stock is technically in a Mildly Bearish range
  • The stocks MACD and KST technical factors are also Bearish
4
With ROCE of 12.6, it has a Very Attractive valuation with a 1.9 Enterprise value to Capital Employed
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -18.43%, its profits have risen by 9.4% ; the PEG ratio of the company is 2.1
5
High Institutional Holdings at 20.38%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
6
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -18.43% returns in the last 1 year, the stock has also underperformed BSE500 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Specialty Chemicals)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Rossari Biotech for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Rossari Biotech
-21.37%
-0.53
34.87%
Sensex
-1.65%
-0.49
12.94%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
25.14%
EBIT Growth (5y)
13.59%
EBIT to Interest (avg)
8.87
Debt to EBITDA (avg)
0.60
Net Debt to Equity (avg)
0.23
Sales to Capital Employed (avg)
1.55
Tax Ratio
26.16%
Dividend Payout Ratio
1.86%
Pledged Shares
0
Institutional Holding
16.66%
ROCE (avg)
16.27%
ROE (avg)
11.80%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
19
Industry P/E
44
Price to Book Value
2.12
EV to EBIT
14.79
EV to EBITDA
10.48
EV to Capital Employed
1.91
EV to Sales
1.23
PEG Ratio
1.62
Dividend Yield
0.10%
ROCE (Latest)
12.59%
ROE (Latest)
11.19%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

6What is working for the Company
NET SALES(Q)

Highest at Rs 697.20 cr

PBDIT(Q)

Highest at Rs 80.62 cr.

-16What is not working for the Company
OPERATING PROFIT TO INTEREST(Q)

Lowest at 7.34 times

OPERATING CF(Y)

Lowest at Rs 58.73 Cr

DEBT-EQUITY RATIO(HY)

Highest at 0.33 times

DPR(Y)

Lowest at 1.94%

INTEREST(Q)

Highest at Rs 10.98 cr

PAT(Q)

At Rs 35.10 cr has Fallen at -5.9% (vs previous 4Q average

Loading Valuation Snapshot...
Here's what is working for Rossari Biotech
Net Sales - Quarterly
Highest at Rs 697.20 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 80.62 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Here's what is not working for Rossari Biotech
Operating Profit to Interest - Quarterly
Lowest at 7.34 times and Fallen
each quarter in the last five quarters
MOJO Watch
The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Debt-Equity Ratio - Half Yearly
Highest at 0.33 times and Grown
each half year in the last five half yearly periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Operating Cash Flow - Annually
Lowest at Rs 58.73 Cr
in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (Rs Cr)

Interest - Quarterly
Highest at Rs 10.98 cr
in the last five quarters and Increased by 21.19 % (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (Rs cr)

Profit After Tax (PAT) - Quarterly
At Rs 35.10 cr has Fallen at -5.9% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 37.31 Cr
MOJO Watch
Near term PAT trend is negative

PAT (Rs Cr)

Dividend Payout Ratio (DPR) - Annually
Lowest at 1.94%
in the last five years
MOJO Watch
Company is distributing lower proportion of profits generated as dividend

DPR (%)